导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.50% | 253/354 |
| 近一周 | -2.49% | 227/356 |
| 近一月 | -5.27% | 257/362 |
| 近一季 | -7.65% | 284/362 |
| 近半年 | -2.44% | 233/358 |
| 近一年 | -8.84% | 208/349 |
| 近两年 | 8.63% | 263/314 |
| 近三年 | 4.25% | 186/244 |
| 成立以来 | 82.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-12.88% 274/360 |
4.95% 165/366 |
- - |
- - |
| 2025 | 14.53% 238/358 |
-5.89% 231/340 |
11.23% 122/348 |
7.67% 197/354 |
1.62% 77/358 |
| 2024 | 3.14% 219/329 |
7.46% 85/280 |
-8.27% 279/310 |
4.87% 165/318 |
-0.22% 146/329 |
| 2023 | 8.80% 90/275 |
18.46% 23/205 |
1.29% 116/230 |
-16.12% 228/262 |
8.09% 118/276 |
| 2022 | -22.14% 111/201 |
-9.34% 81/153 |
-19.24% 138/164 |
-3.43% 56/189 |
10.11% 106/202 |
| 2021 | 18.68% 44/150 |
2.09% 134/312 |
9.77% 64/328 |
-7.14% 201/358 |
14.04% 6/151 |
| 2020 | 32.11% 23/103 |
-21.67% 220/280 |
20.99% 92/295 |
15.27% 13/299 |
20.94% 18/305 |
| 2019 | 25.64% 32/88 |
12.90% 75/258 |
3.15% 84/268 |
-3.49% 213/253 |
11.78% 42/266 |
| 2018 | -13.36% 56/79 |
- - |
- - |
- - |
-14.78% 168/241 |
| 2017 | 34.52% 5/69 |
- - |
- - |
- - |
- - |
| 2016 | -2.94% 42/59 |
- - |
- - |
- - |
- - |
| 2015 | -5.13% 30/49 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 易方达标普消费品指数美元现汇A VS. 建信富时100指数(QDII)人民币A(539003) |